TKTalia Kakourou

Talia Kakourou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Talia Kakourou has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Real-World Data from the Use of Ranolazine in Patients with Stable Angina Pectoris: The RANGER Study

    by Christoforos Olympios, Panagiotis Stafylas, Alkiviadis Dermitzakis, Ioannis Efthimiadis, Alexandros Gardikiotis, Stavros Kakouros, Stylianos Lampropoulos, John Barbetseas, Angelos Sourgounis, on behalf of RANGER Investigators

    Background: Although ranolazine has been available for years as a second-line treatment to reduce angina attacks in patients with stable angina pectoris, real-world data on the effectiveness, tolerability, and safety of ranolazine are limited. Methods: A non-interventional, prospective study was conducted to assess the effectiveness and safety of ranolazine. Patients eligible for enrolment had a baseline assessment between one and fourteen days after initiating ranolazine for the first time and a follow-up visit three months later. The primary endpoints comprised the weekly frequency of angina attacks, total adverse events, and ranolazine discontinuation rate. The secondary endpoints included the use of short-acting nitrates, changes on the Canadian Cardiovascular Society (CCS) angina classification score and quality of life scale score (QoL). Results: In total, 1101 patients were enrolled at 214 sites. Mean weekly angina attacks were reduced from 3.6 ± 2.9 to 0.4 ± 0.9 (p < 0.0001) and the mean weekly consumption of short-acting nitrates decreased by 1.7 ± 2.2 (p < 0.0001). CCS class and QoL were also improved (p < 0.0001). Adverse events were reported by 11 (1%) patients in total, while 2 of them (0.2%) were characterised as serious. Treatment was discontinued for various reasons in 23 patients (2.1%) after the follow-up period. Ranolazine treatment was equally effective in all subgroups tested, with larger benefits observed in patients with more frequent angina and CCS angina class III and IV. Up-titration of ranolazine during the study improved the outcomes. Conclusions: Ranolazine was well tolerated and effectively reduced angina attacks, with simultaneous improvement of the CCS class and QoL score in patients with stable angina.


  • Open Access

    Mycoplasma pneumoniae as a cause of vulvar ulcers in a non-sexually active girl: a case report

    by Maria G. Koliou, Talia Kakourou, Jan Richter, Christina Christodoulou, Elpidoforos S. Soteriades

    Non-sexually active young females very rarely develop genital ulcers. Such ulcers pose a diagnostic challenge as well as physical and emotional distress for patients and family; therefore, the search for their etiology requires exhaustive investigation. Several viruses such as Epstein–Barr virus have been associated with this entity; however, Mycoplasma pneumoniae has rarely been linked to such ulcers in the literature. We present a case of vulvar ulcers in a non-sexually active young girl during the course of pneumonia caused by Mycoplasma pneumoniae. A 10-year-old non-sexually active girl of cypriot origin presented at a hospital with fever, dry cough, and acute vulvar ulcers. Laboratory investigations as well as imaging studies revealed Mycoplasma pneumoniae as the cause of her pneumonia and acute vulvar ulcers. Although a rare cause of vulvar ulcers, Mycoplasma pneumoniae should be considered in the differential diagnosis of acute vulvar ulcers coexisting with respiratory symptoms.


  • Open Access

    Erratum To:Clinical and genetic characterization of chanarin-dorfman syndrome patients: first report of large deletions in the ABHD5 gene

    by Chiara Redaelli, Rosalind A Coleman, Laura Moro, Amalia Sertedaki, Talia Kakourou, Solaf Mohamed Elsayed, Daniele Prati, Agostino Colli, Donatella Mela, Roberto Colombo, et al.


  • Vitiligo in children

    by Talia Kakourou

    Vitiligo is an acquired depigmentary disorder affecting around 1% of the world’s population. In 25% of cases it has its onset prior to the age of 14 years. Articles on vitiligo in children published after 1995 were retrieved from PubMed. The prevalence, etiology, clinical presentation, differential diagnosis, treatment and management of vitiligo in children were summarized. Vitiligo is characterized by acquired, sharply demarcated depigmented macules or patches on the skin, the mucous membranes and/or white hair and it is mainly differentiated from congenital achromic skin lesions. It is frequently associated with various autoimmune diseases. Hashimoto’s thyroiditis is the most common association in children. Information on the nature, possible causes and course of the disease leads to acceptance of the disorder and higher compliance with the treatment. The choice of medical treatment depends on the type, location and duration of lesions as well as the eagerness of the child and his/her parents to pursue therapy. The management of childhood vitiligo includes information and reassurance of young patients and their parents on the disease, thyroid investigation, avoidance of trigger factors, topical treatment and proper follow-up.


  • A case series of alopecia areata in children: impact of personal and family history of stress and autoimmunity

    by T Kakourou, K Karachristou, G Chrousos

    Background  The epidemiology of alopecia areata (AA) is well documented in adults but has not been studied adequately in children.Objective  To evaluate the clinical and epidemiological profile of AA in children and assess the significance of thyroid screening.Methods  One hundred and fifty‐seven children (83 boys, 74 girls, aged 1–16 years) who visited our clinic with a first episode of AA from 1996 to 2000 were retrospectively studied. One hundred children served as clinical controls.Results  The age of peak incidence of AA was 0–5 years. The youngest child was 1 year old. In the majority of the cases (131/157, 83.4%) the disease was mild or moderate (less than 50% hair loss). In 15 patients (9.5%), AA was preceded by a stressful event. Five patients had a personal history of autoimmune disease (3.2 vs. 5% of the controls, (P = not significant [NS]) while 18 patients had a personal history of atopy (11.4 vs. 18% of the controls, P = NS). Twenty‐one patients had a family history of autoimmune disease other than thyroiditis (13.4 vs. 5% of the controls, P = 0.04), while 23 patients had a family history of thyroid disorder (14.6 vs. 3% of the controls, P = 0.006). In eight patients (5%) subclinical hypothyroidism of autoimmune aetiology (Hashimoto's thyroiditis) was revealed at the time of investigation. Six out of the eight patients with Hashimoto's thyroiditis had a family history of thyroid disorder, which was statistically significant when compared to AA patients without thyroiditis (P < 0.001). The severity of AA was associated with early age of onset of the disease (P = 0.02).Conclusion  The age of peak incidence of AA in children is 0–5 years. Children with AA have an increased family history of autoimmunity, and, among children with a first episode and short duration of AA (< 6 months), thyroid screening might be restricted in those with a positive family history of thyroid disorder. Thyroid screening should be routinely performed in all children with long‐standing AA.


  • Increased prevalence of chronic autoimmune (Hashimoto's) thyroiditis in children and adolescents with vitiligo

    by Talia Kakourou, Christina Kanaka-Gantenbein, Anna Papadopoulou, Eirini Kaloumenou, George P. Chrousos


  • Low serum insulin values in children with multiple lesions of granuloma annulare: a prospective study

    by T Kakourou, F Psychou, A Voutetakis, A Xaidara, K Stefanaki, C Dacou-Voutetakis

    The relationship between granuloma annularae (GA) and diabetes mellitus (DM) is controversial. To investigate the relationship between multiple lesions of GA and carbohydrate metabolism in children. Fifteen children (seven boys, eight girls, mean age 4.8 years) with five or more lesions of GA were evaluated. A personal and family history of DM or other autoimmune diseases was obtained and the glycaemic and insulin response during an oral glucose tolerance test (OGTT) was determined. Thirteen children with a negative personal and family history of DM served as controls for the OGTT and 100 other children as 'clinical controls'. At the 30-min sampling of the OGTT the mean insulin values were comparable in GA children and controls (P=0.1), while the mean glucose values were significantly higher in GA children than in controls (P=0.005). All other insulin values during the OGTT were significantly lower in GA children than in controls, while all other glucose values were comparable in GA children and controls with all indices applied. Eleven out of 15 GA children had a positive family history of DM (73.3% vs. 16% of the clinical controls; P<0.0001). Multiple lesions of GA in children are associated with significantly lower serum insulin values than in controls and mildly impaired glucose tolerance.


  • Molluscum contagiosum in Greek children: a case series

    by Talia Kakourou, Asimina Zachariades, Tasos Anastasiou, Eleni Architectonidou, Sofia Georgala, Maria Theodoridou

    Background  Epidemiological studies of molluscum contagiosum (MC) in children are limited.Patients and method  Between 1997 and 1999, 110 children with MC (60 boys, 50 girls, mean age: 4.8 years) were studied. Treatment consisted of removal of all MC lesions in a single session by sterilized tweezers.Results  In children aged ≤ 2 years, the MC lesions were located mainly on the face, whereas in older children they were located on the trunk. Twenty children had atopic dermatitis (18.2% vs. 5% of Greek children aged 1–6 years; P < 0.001). Four children had numerous and recurrent MC lesions without any other systemic manifestations. In these children, humoral and cellular immunities were found to be normal. Seventy‐seven children (70%) were cured after one treatment session, 22 children (20%) after a second session and 11 (10%) after ≥ three sessions. No patients experienced secondary bacterial infection or scarring.Conclusions  In contrast to cool climates where the age of peak incidence of MC in children is 10–12 years, in a warm country such as Greece, it is at the younger age of 4.8 years. In young children aged 2 years, the MC lesions are located mainly on the face, whereas in older children they are located on the trunk. Atopic dermatitis is a predisposing factor for MC. In cases where MC lesions are numerous and/or persist but there are no other signs of systemic infections, the possibility of immunodeficiency is minimal. Removal of MC lesions by tweezers is an efficient, simple and inexpensive method of treatment without sequelae.


  • Vesiculopapular rash as a single presentation in intrauterine coxsackie virus infection

    by Maria Theodoridou, Talia Kakourou, Ioanna Laina, Glyceria Mostrou, Athanassios Tsakris